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Just over 2000 bacterial species have been cultured at least
once from clinical specimens, and more species undoubtfully
remain to be cultured. The same enumeration remains to be
performed for viruses and microeukaryotes in human micro-
biota [1]. Culturing a microbe remains the goal in microbiol-
ogy, as the cultured microbe is an unsurpassed starting point
for obtaining knowledge, opening the door to fully under-
standing and eventually manipulating the microbe, including
prevention of colonization and disease through vaccination and
treatment. Accordingly, pathogens were among the very ﬁrst
microbes to be cultured, and in this thematic issue of Clinical
Microbiology and Infection we tell the story of the discovery of
four such big killers, illustrating the sometimes tortuous
pathway of microbial discovery. Theves et al. [2] report on the
discovery of smallpox, and Cambau [3], Lippi [4] and Butler [5]
report on the discovery of Mycobacterium tuberculosis, Vibrio
cholerae, and Yersinia pestis, respectively.
The four stories provide lessons on which to base our
research in clinical microbiology. In no case did the initial
discovery of the pathogen arrive from nowhere; it depended
on a previous corpus of popular, empirical and scientiﬁc
knowledge. In particular, these four quite different infectious
diseases had been recognized for centuries as speciﬁc entities
by populations and doctors, through a combination of
epidemiological and clinical observations, such as epidemics
and swollen lymph nodes (buboes) in the case of plague [5].
Paleomicrobiology, which is concerned with the retrospective
history of microbes and the diseases that they caused [6], now
allows us to appreciate this aspect, as smallpox virus [7],
M. tuberculosis [8] and Y. pestis [9] have been detected in
suitable ancient specimens, being, respectively, the skin, bones,
and dental pulp. V. cholerae has been detected in ancient
specimens, using the suitable material (the intestinal contents
of cholera victims) [10].
Discovering a new pathogen has often relied on the
development and use of new technology. Microscopy, more
precisely microscopy improvement, contributed to the
discovery of M. tuberculosis by Robert Koch in 1882, as he
invented a new staining method [3]; and the use of electron
microscopy was decisive in the case of smallpox [2]. Interest-
ingly, in 1854, both John Snow in London and Filippo Paccini in
Florence also used optical microscopy as part as their
investigation of cholera epidemics, but failed to go further in
culturing V. cholerae, which was ﬁnally isolated by Koch
30 years later [4]. Indeed, the use of solid culture medium
instead of broth, previously developed in Louis Pasteur’s
laboratory, was a decisive step in the initial isolation of
M. tuberculosis and V. cholerae by Koch [3,4]. For plague, the
use of an ambient temperature instead of 37°C contributed to
the success of Alexandre Yersin in 1894, in addition to the
culture of diseased lymph nodes instead of blood [5].
However, two major pathogens, i.e. Treponema pallidum and
Mycobacterium leprae, remain to be cultured in axenic medium,
as they have been propagated only in animals. Today, the
discovery of microbes has moved towards organisms in
complex microbiota, including bypassing organisms, resident
organisms, and opportunistic pathogens. Bacterial culturomics,
using diversiﬁcation of culture media and culture conditions
(atmosphere and temperature of incubation), now yields
hundreds of colonies per culture plate to be identiﬁed [11].
This rebirth of culture has been made possible by a new
technology for the rapid identiﬁcation of such huge numbers of
colonies, matrix-assisted laser desorption ionization time-of--
ﬂight mass spectrometry [12]. Therefore, more and more
organisms are being discovered together, cultured in the same
laboratory from the very same specimen, in contrast to the
singular history of their predecessors.
Also, the four histories reported in this thematic issue teach
us to avoid some of the pitfalls of scientiﬁc communication in
microbiology, the last but not least step of microbe discovery.
The dispute over who was the very ﬁrst discoverer of Y. pestis,
after the controversial 1894 paper by Shibasaburo Kitasato in
the Lancet, is well known [5,13]. A rush to publish before a
pure culture of the new microbe had been obtained, and
mixing his own data with those of another doctor, led Kitasato
to publish inaccurate data, and ﬁnally tarnished the glory of the
discoverer of Clostridium tetani. The inﬂuence of Kitasato’s
reputation, preventing a neutral review of the data by the
Lancet, also had a negative role in this history [14]. Ignoring and
under-reporting previously published data is another pitfall
ª2014 The Authors
Clinical Microbiology and Infection ª2014 European Society of Clinical Microbiology and Infectious Diseases
EDITORIAL 10.1111/1469-0691.12533
when dealing with microbe discovery. Even the Nobel prize
winner Koch failed to mention previous work by Jean Antoine
Villemin [15], who, in 1865, established the transmissibility of
tuberculosis, in his very ﬁrst paper on M. tuberculosis [16];
Koch ﬁnally acknowledged this contribution in his second
paper, published 2 years later in 1884 [17]. Likewise, Koch
clearly missed previous work by Paccini regarding the
discovery of V. cholerae [4].
In conclusion, the four microbe discovery stories reported
here are a source of lessons for microbiologists searching for
new microbes. The use of new laboratory tools and new
concepts is a source of discovery. Fair reporting of unique
discoveries, using modern standards of species deﬁnition and
modern tools to communicate, is a source of durability.
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